Adenocarcinomas News and Research

RSS
New targeted therapy provides survival benefit in KRAS G12C-mutated lung cancer

New targeted therapy provides survival benefit in KRAS G12C-mutated lung cancer

Single-cell map offers a new immunotherapy target for lung cancer treatment

Single-cell map offers a new immunotherapy target for lung cancer treatment

Lung cancer cells activate different signaling pathways in response to KRAS inhibitors

Lung cancer cells activate different signaling pathways in response to KRAS inhibitors

Dynamic, customized treatment approaches for gastroesophageal cancers may improve survival rates

Dynamic, customized treatment approaches for gastroesophageal cancers may improve survival rates

Novel organoid models illuminate path to cervical cancers

Novel organoid models illuminate path to cervical cancers

Surprising discovery reveals new target for aggressive lung adenocarcinoma

Surprising discovery reveals new target for aggressive lung adenocarcinoma

Scientists identify new target for developing novel drugs against several types of cancer

Scientists identify new target for developing novel drugs against several types of cancer

Sortilin may hold the key to developing more effective treatment for pancreatic cancer

Sortilin may hold the key to developing more effective treatment for pancreatic cancer

Gum disease and esophageal and stomach cancer risk

Gum disease and esophageal and stomach cancer risk

Quest Diagnostics Health Trends study: HPV screening less likely to detect cervical cancer than cotesting

Quest Diagnostics Health Trends study: HPV screening less likely to detect cervical cancer than cotesting

Study suggests new potential strategy to fight against pancreatic cancer

Study suggests new potential strategy to fight against pancreatic cancer

UCI makes tremendous strides in prevention, early detection and treatment of cancer

UCI makes tremendous strides in prevention, early detection and treatment of cancer

Purdue-developed 'fluorescent markers' begin Phase 3 clinical trials

Purdue-developed 'fluorescent markers' begin Phase 3 clinical trials

New technology enhances visualization of lung cancer tissue, helps improve patient outcomes

New technology enhances visualization of lung cancer tissue, helps improve patient outcomes

RB1 alterations in cancer cells may lead to treatment resistance

RB1 alterations in cancer cells may lead to treatment resistance

UChicago expert sheds light on pancreatic neuroendocrine tumors

UChicago expert sheds light on pancreatic neuroendocrine tumors

GW researchers show connection between bacteria in the microbiome and colon cancer

GW researchers show connection between bacteria in the microbiome and colon cancer

Combination therapies can shrink lung tumors in mice and human cancer cells

Combination therapies can shrink lung tumors in mice and human cancer cells

Distinctive characteristics in lung cancers could be key to personalized therapies

Distinctive characteristics in lung cancers could be key to personalized therapies

New study helps explain why lung tumors turn aggressive

New study helps explain why lung tumors turn aggressive